Finding kinder drugs in genetically matched cell models for childhood leukaemia
Current treatments for childhood leukaemia are effective but often damage healthy cells. As a result, patients often have lifelong health problems. Our research aims to identify "kinder" drugs by using genetically engineered "twin" cells to compare how healthy and cancerous cells respond to treatment.